Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-39 av 39

2023
1 Dyrhovden, Ruben; Eagan, Tomas Mikal Lind; Fløtten, Øystein; Siljan, William Ward; Leegaard, Truls Michael; Bø, Bjørnar; Fardal, Hilde; Grøvan, Fredrik; Kildahl-Andersen, Arne; Larssen, Kjersti Wik; Tilseth, Rune Hørgård; Hjetland, Reidar; Løes, Sigbjørn Suk; Lindemark, Frode; Tellevik, Marit Gjerde; Breistein, Rebecca Irene; Kommedal, Øyvind.
Pleural Empyema Caused by Streptococcus intermedius and Fusobacterium nucleatum: A Distinct Entity of Pleural Infections. Clinical Infectious Diseases 2023 ;Volum 77.(10) s. 1361-1371
HAUKELAND UiB AHUS UiO SUS HVprivate STO HELSEFØRDE UiT Untitled
 
2 Orstad, Silje; Fløtten, Øystein; Madebo, Tesfaye; Gulbrandsen, Pål; Strand, Roger; Lindemark, Frode; Fluge, Sverre; Tilseth, Rune Hørgård; Schaufel, Margrethe Aase.
“The challenge is the complexity” – A qualitative study about decision-making in advanced lung cancer treatment. Lung Cancer 2023 ;Volum 183. s. -
HELSEFONNA HAUKELAND UiB SUS UiO AHUS HELSEFØRDE Untitled
 
2022
3 Gärtner, Fabian; Assmus, Jörg; Fløtten, Øystein; Ramnefjell, Maria; Aanerud, Marianne.
Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway. Acta Oncologica 2022 ;Volum 61.(7) s. 814-818
HAUKELAND UiB Untitled
 
4 Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan; HORNSLIEN, KJERSTI; Madebo, Tesfaye; Schytte, Tine; Risum, Signe; Tsakonas, Georgios; Engleson, Jens; Grønberg, Bjørn Henning.
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer 2022 ;Volum 166. s. 49-57
OUS SUS HAUKELAND STO VV NTNU Untitled
 
5 Kristensen, Are Korsnes; Grønberg, Bjørn Henning; Fløtten, Øystein; Kaasa, Stein; Solheim, Tora S.
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer. Supportive Care in Cancer 2022 ;Volum 30. s. 9351-9358
OUS NTNU STO HAUKELAND UiO Untitled
 
2021
6 Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye; Langer, Seppo Wang; Schytte, Tine; Nyman, Jan; Risum, Signe; Tsakonas, Georgios; Engleson, Jens; Halvorsen, Tarje Onsøien.
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology 2021 ;Volum 22.(3) s. 321-331
NTNU STO HAUKELAND VV OUS SUS Untitled
 
2020
7 Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje; Fløtten, Øystein; Helbekkmo, Nina; Hornslien, Kjersti; Madebo, Tesfaye; Fluge, Sverre; Grønberg, Bjørn Henning.
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica 2020 s. -
NTNU STO OUS HAUKELAND UNN SUS HELSEFONNA Untitled
 
2019
8 Fløtten, Øystein.
Simplifying Treatment of Advanced Non-small Cell Lung Cancer. Regimen, Route of Administration, and Patients' Preferences. : Universitetet i Bergen 2019 (ISBN 9788230855188)
UiB Untitled
 
2018
9 Grønberg, Bjørn Henning; Sjøblom, Bjørg; Wentzel-Larsen, Tore; Baracos, Vickie Elaine; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Bremnes, Roy M.; Fløtten, Øystein; Bye, Asta; Jordhøy, Marit Slaaen.
A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer. European Journal of Clinical Nutrition 2018 s. 1-8
NTNU STO OUS NKVTS HAUKELAND UiO UiT UNN OSLOMET SI RBUP-ØS Untitled
 
10 Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Fløtten, Øystein; Grønberg, Bjørn Henning.
Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small- cell lung cancer. ESMO congress 2018; 2018-10-19 - 2018-10-23
NTNU UiT Untitled
 
11 Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Fløtten, Øystein; Grønberg, Bjørn Henning.
Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials. Acta Oncologica 2018 ;Volum 57.(11) s. 1574-1579
NTNU STO HAUKELAND Untitled
 
12 Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M.; Brunsvig, Paal Fr.; Brustugun, Odd Terje; Fløtten, Øystein; Levin, Nina; Sundstrøm, Stein Harald; Grønberg, Bjørn Henning.
Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research 2018 ;Volum 38.(2) s. 871-876
UiT OUS STO NTNU UNN VV UiO Untitled
 
2017
13 Bye, Asta; Sjøblom, Bjørg; Wentzel-Larsen, Tore; Grønberg, Bjørn Henning; Baracos, Vickie E.; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Bremnes, Roy M.; Fløtten, Øystein; Jordhøy, Marit Slaaen.
Muscle mass and association to quality of life in non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle 2017 ;Volum 8. s. 759-767
OSLOMET OUS UiO SI NTNU HAUKELAND NKVTS STO UiT UNN Untitled
 
14 Pedersen, Jesper Holst; Sørensen, Jens Benn; Saghir, Zaigham; Fløtten, Øystein; Brustugun, Odd Terje; Ashraf, Haseem; Strand, Trond-Eirik; Friesland, Signe; Koyi, Hirsh; Ek, Lars; Nyrén, Sven; Bergman, Per; Jekunen, Antti; Nieminen, Eeva-Maija; Gudbjartsson, Tomas.
Implementation of lung cancer CT screening in the Nordic countries. Acta Oncologica 2017 ;Volum 56.(10) s. 1249-1257
AHUS HAUKELAND VV KREFTREG Untitled
 
15 Sjøblom, Bjørg; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Baracos, Vickie E.; Sawyer, Michael; Fløtten, Øystein; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Jordhøy, Marit Slaaen.
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer 2017 ;Volum 18.(2) s. e129-e136
AHUS HAUKELAND NTNU UiO STO SI OUS Untitled
 
2016
16 Chatterjee, Manash; Turner, David C.; Felip, Enriqueta; Léna, Hervé; Cappuzzo, Federico; Horn, Leora A.; Garon, Edward B.; Hui, Rina; Arkenau, Hendrik Tobias; Gubens, Matthew A.; Hellmann, Matthew D.; Dong, David; Li, Claire; Mayawala, Kapil; Freshwater, Tomoko; Ahamadi, Malidi; Stone, Julie A.; Lubiniecki, Gregory M.; Zhang, Jin; Im, Ellie; De Alwis, Dinesh P.; Kondic, Anna Georgieva; Fløtten, Øystein.
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Annals of Oncology 2016 ;Volum 27.(7) s. 1291-1298
HAUKELAND Untitled
 
17 Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise; Hald, Sigurd; Al-Saad, Samer; Brustugun, Odd Terje; Helland, Åslaug; Lund-Iversen, Marius; Solberg, Steinar; Grønberg, Bjørn Henning; Wahl, Sissel Gyrid Freim; Helgeland, Lars; Fløtten, Øystein; Pohl, M; Al-Shibli, Khalid; Sandanger, Torkjel M; Pezzella, Francesco; Busund, Lill-Tove; Bremnes, Roy M..
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology 2016 ;Volum 27.(2) s. 225-232
NLSH UiT NTNU OUS STO UNN HAUKELAND Untitled
 
18 Fløtten, Øystein; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Helbekkmo, Nina; Bremnes, Roy M.; Plessen, Christian von.
Oral versus intravenous vinorelbine in advanced NSCLC - a retrospective comparison. Cancer Treatment and Research Communications 2016 ;Volum 9. s. 15-20
NTNU UiT UNN HAUKELAND STO Untitled
 
19 Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Tollåli, Terje; Hornslien, Kjersti; Aksnessæther, Bjørg Y.; Liaaen, Erik Dyb; Sundstrøm, Stein Harald.
Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer. Acta Oncologica 2016 ;Volum 55.(5) s. 591-597
NTNU UNN OUS STO NLSH UiT HAUKELAND HMR UiO Untitled
 
20 Halvorsen, Tarje Onsøien; Herje, Martin; Levin, Nina; Bremnes, Roy M.; Brustugun, Odd Terje; Fløtten, Øystein; Kaasa, Stein; Sundstrøm, Stein Harald; Grønberg, Bjørn Henning.
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer. Lung Cancer 2016 ;Volum 102. s. 9-14
UNN NTNU STO OUS HAUKELAND UiO UiT Untitled
 
21 Halvorsen, Tarje Onsøien; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Kaasa, Stein; Grønberg, Bjørn Henning.
Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer. Acta Oncologica 2016 ;Volum 55.(11) s. 1349-1354
NTNU STO HAUKELAND OUS UiO UiT UNN Untitled
 
22 Sjøblom, Bjørg; Grønberg, Bjørn Henning; Wentzel-Larsen, Tore; Baracos, Vickie E.; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Bremnes, Roy M.; Fløtten, Øystein; Bye, Asta; Jordhøy, Marit Slaaen.
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Clinical Nutrition 2016 ;Volum 35.(6) s. 1386-1393
UiT UiO NTNU HAUKELAND OUS NKVTS SI STO RBUP-ØS OSLOMET UNN Untitled
 
2015
23 Grønberg, Bjørn Henning; Levin, Nina; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Bremnes, Roy M.; Kaasa, Stein; Halvorsen, Tarje Onsøien.
Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC).. Journal of Clinical Oncology 2015 ;Volum 33. Suppl. abstr e 18553
OUS STO HAUKELAND UiT NTNU UiO Untitled
 
24 Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Kaasa, Stein; Halvorsen, Tarje Onsøien.
Association between comorbidity, treatment toxicity and overall survival in limited disease small-cell lung cancer. 16TH WORLD CONFERENCE ON LUNG CANCER; 2015-09-06 - 2015-09-09
HAUKELAND NTNU OUS STO UiO UiT Untitled
 
25 Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Bremnes, Roy M.; Kaasa, Stein; Halvorsen, Tarje Onsøien.
Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology 2015 ;Volum 10.(9) Suppl. 2 s. s744-
UiT HAUKELAND NTNU OUS STO Untitled
 
26 Sjøblom, Bjørg; Grønberg, Bjørn Henning; Saltyte Benth, Jurate; Baracos, Vickie E.; Fløtten, Øystein; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Jordhøy, Marit.
Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Lung Cancer 2015 ;Volum 90.(1) s. 85-91
UiO NTNU HAUKELAND SI OUS STO AHUS Untitled
 
27 Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr.; Fløtten, Øystein; Brustugun, Odd Terje; Sundstrøm, Stein Harald; Grønberg, Bjørn Henning.
Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. Journal of Thoracic Oncology 2015 ;Volum 10.(9) Suppl. 2 s. s744-
UiT UiO HAUKELAND STO NTNU OUS Untitled
 
2013
28 Amundsen, Tore; Fløtten, Øystein; Bugge, Anders Standal; Fjellbirkeland, Lars; Richardsen, Elin; Nesgård, Kristin; Johnsen, Boel; Heitmann, Ellinor.
Nasjonal handlingsplan for lungekreft (for Helsedirektoratet, HD og Norwegian Lung Cancer Group, NLCG) - utredning og behandling (utredningskapittelet).
HAUKELAND NTNU STO UiO UiT VV Untitled
 
29 Strøm, Hans Henrik; Bremnes, Roy M.; Sundstrøm, Stein Harald; Helbekkmo, Nina; Fløtten, Øystein; Aasebø, Ulf.
Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group. British Journal of Cancer 2013 ;Volum 109.(6) s. 1467-1475
STO UNN UiT HAUKELAND HELSEHELG Untitled
 
2012
30 Fløtten, Øystein; Grønberg, Bjørn Henning; Bremnes, Roy M.; Amundsen, Tore; Sundstrøm, Stein Harald; Rolke, Heidi; HORNSLIEN, KJERSTI; Wentzel-Larsen, Tore; Aasebø, Ulf; von Plessen, Christian.
Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. British Journal of Cancer 2012 ;Volum 107.(3) s. 442-447
UNN NTNU STO HAUKELAND UiT SSHF OUS NKVTS UiB RBUP-ØS Untitled
 
31 Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuuttila, A; Abel, Edvard; Langer, Seppo; Krejcy, Kurt; Liepa, AM; Munoz, Maria; Hahka-Kemppinen, Marjo; Sundstrøm, Stein Harald.
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer. Lung Cancer 2012 ;Volum 78.(1) s. 63-69
STO NTNU HAUKELAND Untitled
 
32 Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Tollali, Terje; HORNSLIEN, KJERSTI; Aksnessæther, Bjørg Y.; Liaaen, Erik Dyb; Sundstrøm, Stein Harald.
Randomized phase II trial comparing two schedules of thoracic radiotherapy (TRT) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology 2012 ;Volum 30.(15) s. -
UiO NTNU HAUKELAND OUS UiT STO HMR Untitled
 
33 Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Tollåli, Terje; HORNSLIEN, KJERSTI; Aksnessæther, Bjørg Y.; Liaaen, Erik Dyb; Sundstrøm, Stein Harald.
Phase II Trial Comparing Two Schedules of Thoracic Radiotherapy in Limited Disease Small-Cell Lung Cancer. ASCO Annual Meeting 2012; 2012-06-01 - 2012-06-05
HAUKELAND HMR NLSH NTNU OUS STO UiT Untitled
 
2011
34 Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuutila, Aija; Abel, Edvard; Langer, Seppo; Munoz, Maria; Hahka-Kemppinen, Marjo; Sundstrøm, Stein Harald.
Randomized Phase Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer: The MENZA Study. The European Multidisciplinary Cancer Congress ECCO 16; 2011-09-24 - 2011-09-27
HAUKELAND NTNU STO Untitled
 
35 Grønberg, Bjørn Henning; Ciuleanu, Tudor; Fløtten, Øystein; Knuutila, Aija; Abel, Edvard; Langer, Seppo; Munoz, Maria; Hahka-Kemppinen, Marjo; Sundstrøm, Stein Harald.
Randomized Phase Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer: The MENZA Study. European Journal of Cancer 2011 ;Volum 47. Suppl. 1 s. 640-640
NTNU HAUKELAND STO Untitled
 
2010
36 Fløtten, Øystein; Bremnes, Roy M.; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Amundsen, Tore; Rolke, Heidi; Aasebø, Ulf; hornslien, t; Wentzel-Larsen, Tore; von Plessen, Christian.
Phase III study comparing vinorelbine-gemcitabine with vinorelbine-carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. ASCO; 2010-06-04 - 2010-06-08
HAUKELAND NTNU SSHF STO UiB UiT Untitled
 
37 Fløtten, Øystein; Bremnes, Roy M.; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Amundsen, Tore; Rolke, Heidi; Aasebø, Ulf; hornslien, t; Wentzel-Larsen, Tore; von Plessen, Christian.
Phase III study comparing vinorelbine-gemcitabine with vinorelbine-carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial. ASCO Annual meeting; 2010-06-04 - 2010-06-08
HAUKELAND NTNU SSHF STO UiB UiT Untitled
 
38 Grønberg, Bjørn H.; Sundstrøm, Stein; Kaasa, Stein; Bremnes, Roy M.; Fløtten, Øystein; Amundsen, Tore; Hjelde, Harald Harris; von Plessen, Christian; Jordhøy, Marit S.
Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. European Journal of Cancer 2010 ;Volum 46.(12) s. 2225-2234
NTNU UiB UiT HAUKELAND STO SI OUS UNN Untitled
 
2009
39 Grønberg, BH; Bremnes, Roy M.; Aasebø, Ulf; Brunsvig, Paal; Fløtten, Øystein; Amundsen, T; Von Plessen, Christian; Wang, Mari; Sundstrøm, Stein.
A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer. Lung Cancer 2009 ;Volum 63.(1) s. 88-93
UiT NTNU UiB STO HAUKELAND UNN OUS Untitled